Andreas Halvorsen - Viking Global Investors
Holding/activity history for Standard Biotools Inc (LAB)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 58,651,170 | 0.15 | $0.92 | $53,918,021 | SEC | ||
| 2025 Q4 | 58,651,170 | 0.20 | $1.28 | $75,073,498 | SEC | ||
| 2025 Q3 | 58,651,170 | 0.20 | $1.30 | $76,246,521 | SEC | ||
| 2025 Q2 | 58,651,170 | 0.20 | $1.20 | $70,381,404 | SEC | ||
| 2025 Q1 | 58,651,170 | 0.20 | $1.08 | $63,343,264 | SEC | ||
| 2024 Q4 | 58,651,170 | 0.33 | $1.75 | $102,639,548 | SEC | ||
| 2024 Q3 | 58,651,170 | 0.41 | $1.93 | $113,196,758 | SEC | ||
| 2024 Q2 | 58,651,170 | 0.40 | $1.77 | $103,812,571 | SEC | ||
| 2024 Q1 | 58,651,170 | 0.59 | Buy | 0.59 | $2.71 | $158,944,671 | SEC |
| 2022 Q2 | 0 | 0.00 | Sell 100.00% | 0.78 | SEC | ||
| 2022 Q1 | 727,287 | 0.78 | Reduce 14.45% | 0.11 | $263.66 | $191,756,000 | SEC |
| 2021 Q4 | 850,147 | 0.77 | Add 7.38% | 0.05 | $314.21 | $267,125,000 | SEC |
| 2021 Q3 | 791,746 | 0.62 | Reduce 42.35% | 0.49 | $281.44 | $222,829,000 | SEC |
| 2021 Q2 | 1,373,414 | 1.15 | Add 27.02% | 0.24 | $275.85 | $378,856,000 | SEC |
| 2021 Q1 | 1,081,219 | 0.82 | Add 1,044.15% | 0.75 | $255.03 | $275,743,000 | SEC |
| 2020 Q4 | 94,500 | 0.05 | Reduce 78.01% | 0.23 | $203.54 | $19,235,000 | SEC |
| 2020 Q3 | 429,780 | 0.29 | Buy | 0.29 | $188.27 | $80,915,000 | SEC |
| 2016 Q2 | 0 | 0.00 | Sell 100.00% | 0.35 | SEC | ||
| 2016 Q1 | 673,048 | 0.35 | Reduce 79.02% | 1.25 | $117.13 | $78,834,000 | SEC |
| 2015 Q4 | 3,208,708 | 1.58 | Reduce 36.50% | 0.83 | $123.64 | $396,725,000 | SEC |
| 2015 Q3 | 5,053,349 | 2.27 | Buy | 2.27 | $108.47 | $548,137,000 | SEC |
| 2010 Q3 | 0 | 0.00 | Sell 100.00% | 5.54 | SEC | ||
| 2010 Q2 | 35 | 5.54 | Buy | 5.54 | $2,142.86 | $75,000 | SEC |